KINSHASA, Nov 13 (Reuters) - Democratic Republic of Congo has been unable to launch an mpox vaccination campaign in the ...

The key faultline in the negotiations lies between Western nations with major pharmaceutical industry sectors, and poorer ...

No FDA-approved rapid tests exist that specifically test for H5N1, and the first near-point-of-care test for mpox was ...

The World Health Organisation on Monday announced that it is set to convene its Emergency Committee on November 22 to assess ...

Cases of mpox in the region of Congo where a new and more infectious variant was first detected appear to be “plateauing,” ...